A 3242 New Jersey General Assembly · 2026-2027 Regular Session

Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.

This bill requires all health insurance plans in New Jersey to cover continuous glucose monitoring systems prescribed for treating glycogen storage disease, a rare metabolic condition. It applies to hospital service corporations, medical service corporations, health service corporations, individual health insurance policies, group health plans, and health benefits plans. The coverage must be provided at the same level as for other medical conditions, eliminating insurance denials for this specific treatment. This directly affects patients with glycogen storage disease and their insurers, ensuring access to necessary monitoring technology without extra cost barriers.

Issues: ✓ Healthcare

Bill status in committee 1 of 4 stages cleared

Introduction

Jan 2026

Committee Review

Floor Vote

Governor

Introduced Jan 13, 2026 Last action Feb 12, 2026

Maddy AI version diff · 1 comparison

What changed between versions

Introduced → Reprint · 3 edits

MINOR

The bill moved from introduced status to first reprint after being reported by the Assembly Financial Institutions and Insurance Committee on February 12, 2026 with amendments. The main substantive change is in Section 11 (effective date), which now carves out Section 6 for a later effective date of January 1, 2027, specifically for policies under the Small Employer Health Benefits Program (P.L.1992, c.161). A co-sponsor was added and the bill's statement section was removed as part of standard committee processing.

Scope change

The effective date for Section 6 was split: it now applies to small employer health benefits plans under P.L.1992, c.161 on January 1, 2027, while the rest of the act follows the standard seventh-month-after-enactment timeline. The applicability language was also broadened from 'all health benefits plans' to 'policies and contracts.'

TIMELINE

Section 11 now provides that Section 6 of the act takes effect on January 1, 2027 (rather than the general effective date) for policies and contracts delivered, issued, executed, or renewed under P.L.1992, c.161 (the Small Employer Health Benefits Program). This gives small employer plans an additional grace period before the continuous glucose monitoring coverage requirement applies to them.

SCOPE

The applicability language in Section 11 was changed from 'all health benefits plans' to 'policies and contracts,' and the phrase 'in this State' was removed from the first clause covering plans delivered, issued, executed, or renewed. This broadens the terminology and potentially the geographic reach of the applicability provision.

Assemblywoman Heather Simmons (District 3, Cumberland/Gloucester/Salem) was added as a co-sponsor.

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Feb 12, 2026

Committee

Reported out of Asm. Comm. with Amendments, and Referred to Assembly Appropriations Committee

lower

Jan 13, 2026

Introduced

Introduced, Referred to Assembly Financial Institutions and Insurance Committee

lower

2 primary · 1 co-sponsor